PATENT CLAIM ANALYSIS

Application Number: 15741326
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "006900"]

Abstract:
The present invention relates to methods for identifying, assessing, preventing, and treating metabolic disorders and modulating metabolic processes using Slit2.

Claim (Index 11):
A method for modulating a metabolic response comprising contacting a cell with an agent that modulates expression and/or activity of Slit2 or a biologically active fragment thereof to thereby modulate the metabolic response.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13611641', '12446110', '15124795', '14344460', '13143645']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7972692619262919
- 35 USC 102 Novelty (BERT): 0.5282822124678013
- Combined Prediction Score: 0.7703705569804428
- Mean Citation Score: 326.529336
- Max Citation Score: 342.2282
- Similarity Product: 197.8038842176676

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test